SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes is a research paper published in Journal of Clinical Investigation (2021). On theSindex it has a DataRank of 4.2. It has been cited 122 times, with 107 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.722
From this paper's citation signal
Citation Network Contribution
3.5
From 91 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 107 citers.
National Institutes of Health
Grant: U19AI082630,UL1 TR 001102,UL1 TR 002541-01,5P30AI060354
Mark, Lisa and Enid Schwartz Funding
Grant: N/A
EMBO Long-Term Fellowship
Grant: ALTF 486-2018
Cancer Research Institute/Bristol-Myers Squibb Fellow
Grant: CRI2993
NIAID NIH HHS
Grant: U19 AI082630
NCATS NIH HHS
Grant: UL1 TR001102
NIAID NIH HHS
Grant: P30 AI060354
NCATS NIH HHS
Grant: UL1 TR002541
NIAID NIH HHS
Grant: T32 AI007387
National Institutes of Health
Grant: 4UL1TR001102-04
Harvard Clinical and Translational Science Center
National Institutes of Health
Grant: 1P30AI060354-01
Harvard Medical School Center for AIDS Research
National Institutes of Health
Grant: 2U19AI082630-06
Reversal of Immune Failure with Viral Cure in Chronic HCV Infection
FWCI
6.87
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals